Abstract
BACKGROUND: HMG-CoA reductase inhibitors (statins) are widely prescribed in patients with established systolic chronic heart failure (CHF). However, there is considerable controversy regarding their benefit in this setting. We therefore conducted a post-hoc analysis of outcomes according to statin use within the Second Cardiac Insufficiency Bisoprolol Study of the beta-blocker, bisoprolol, in NYHA classes III-IV systolic CHF patients (left ventricular ejection fraction
Original language | English |
---|---|
Pages (from-to) | 28 - 34 |
Number of pages | 7 |
Journal | Cardiology |
Volume | 108 |
Issue number | 1 |
DOIs | |
Publication status | Published - 2007 |